MD1180Z - Method for stimulating the formation of conditioned reflexes in the period of diminution of functions - Google Patents
Method for stimulating the formation of conditioned reflexes in the period of diminution of functionsInfo
- Publication number
- MD1180Z MD1180Z MDS20170030A MDS20170030A MD1180Z MD 1180 Z MD1180 Z MD 1180Z MD S20170030 A MDS20170030 A MD S20170030A MD S20170030 A MDS20170030 A MD S20170030A MD 1180 Z MD1180 Z MD 1180Z
- Authority
- MD
- Moldova
- Prior art keywords
- formation
- period
- diminution
- stimulating
- functions
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention relates to experimental physiology, experimental medicine and pharmacology, in particular to methods for stimulating the formation of conditioned reflexes in the period of diminution of functions.According to the invention, the method comprises the administration as a food additive of Streptomyces fradiae CNMN-Ac-11 strain biomass metabolites, in a dose of 250 mg/kg body weight per day, for 90 days prior to the formation and in the period of formation of conditioned reflexes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20170030A MD1180Z (en) | 2017-03-02 | 2017-03-02 | Method for stimulating the formation of conditioned reflexes in the period of diminution of functions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20170030A MD1180Z (en) | 2017-03-02 | 2017-03-02 | Method for stimulating the formation of conditioned reflexes in the period of diminution of functions |
Publications (2)
Publication Number | Publication Date |
---|---|
MD1180Y MD1180Y (en) | 2017-08-31 |
MD1180Z true MD1180Z (en) | 2018-03-31 |
Family
ID=59759583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDS20170030A MD1180Z (en) | 2017-03-02 | 2017-03-02 | Method for stimulating the formation of conditioned reflexes in the period of diminution of functions |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD1180Z (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1069631A3 (en) * | 1980-07-02 | 1984-01-23 | Эли Лилли Энд Компани (Фирма) | Method for preparing tilactone and strain streptomyces fradiae nrrl 12188 for use in preparing tilactone |
SU1645300A1 (en) * | 1988-12-06 | 1991-04-30 | Научно-Исследовательский Конструкторско-Технологический Институт Биологически Активных Веществ | Streptomyces fradiae strain: producer of restrictase sfr 1 |
-
2017
- 2017-03-02 MD MDS20170030A patent/MD1180Z/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1069631A3 (en) * | 1980-07-02 | 1984-01-23 | Эли Лилли Энд Компани (Фирма) | Method for preparing tilactone and strain streptomyces fradiae nrrl 12188 for use in preparing tilactone |
SU1645300A1 (en) * | 1988-12-06 | 1991-04-30 | Научно-Исследовательский Конструкторско-Технологический Институт Биологически Активных Веществ | Streptomyces fradiae strain: producer of restrictase sfr 1 |
Non-Patent Citations (4)
Title |
---|
Kim W.G. et al. Benzastatins H and I, new benzastatin derivatives with neuronal cell protecting activity from Streptomyces nitrosporeus. In: J. Antibiotics, 2001, vol. 54, р. 513-516 * |
Shin-Ya K. et al. A novel neuronal cell protecting substance mescengricin produced by Streptomyces griseoflavus. In: J. Asian Natural Products Research, 2000, vol. 2, p. 121-132 * |
Shin-Ya K. et al. Novel neuronal cell protecting substances, aestivophoenins A and B, produced by Streptomyces purpeofuscus. In: J. Antibiotics, 1995, vol. 48, is. 11, р. 1378-1381 * |
Шептицкий В.А., Братухина А.А., Бурцева С.А. Условнорефлекторная деятельность белых крыс при длительном потреблении биопрепаратов на основе метаболитов Streptomyces massasporeus. In: Buletinul AŞM. Ştiinţele vieţii, 2007, nr. 2 (302), p. 7-12 * |
Also Published As
Publication number | Publication date |
---|---|
MD1180Y (en) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017008813A (en) | Beetle powder. | |
MX2019006207A (en) | Polymorphic form of sepiapterin. | |
PH12017502379A1 (en) | Drospirenone-based contraceptive for a female patient affected with excess weight | |
WO2018230960A3 (en) | Novel bifidobacterium bifidum strain and strain-derived polysaccharide | |
MX2016009231A (en) | Administration of tasimelteon under fasted conditions. | |
MX2019005040A (en) | Methods and compositions for preventing vector-borne disease transmission. | |
MY194024A (en) | Use of cistanche tubulosa extract and isoacteoside in protection of muscles | |
MX2021014523A (en) | Methods of treating cholangiocarcinoma. | |
AU2012377476A8 (en) | Preparation and method for the prophylaxis and treatment of atypical osteoporosis | |
ZA201905212B (en) | Rescue treatment of post operative nausea and vomiting | |
MD1180Z (en) | Method for stimulating the formation of conditioned reflexes in the period of diminution of functions | |
PH12018502280A1 (en) | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | |
PH12020550104A1 (en) | Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one | |
PH12019502620A1 (en) | 6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative | |
MX2020007062A (en) | Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. | |
WO2016072692A3 (en) | Composition for preventing or treating mucositis comprising necrox as effective ingredient | |
MX2022014158A (en) | Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity. | |
MX2020008129A (en) | Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof. | |
MD3422G2 (en) | Method of prophylaxis and treatment of gallinaceae knemidokoptosis | |
TW201613606A (en) | Therapeutic drug for chronic renal failure | |
MX2020014222A (en) | Therapeutic methods using bacterial strains which are capable of increasing adenosine levels. | |
Cowan | Nausea, hepatitis and diarrhoea: 3 case reports | |
MX2018001528A (en) | Pharmaceutical composition comprising sumatripan for treating migraine. | |
MX2019009733A (en) | 3'deamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-deoxyanthracyclines and methods of preparation. | |
WO2019035143A3 (en) | Medicated honey and method of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG9Y | Short term patent issued | ||
MK4Y | Short term patent expired |